Study Shows Inhaled Medicine Improves Survival for
Lung Transplant Patients
An inhaled drug designed to reduce the odds of a new
lung being rejected after a transplant may dramatically
improve survival afterwards, says a new study from the
University of Pittsburgh.
Read story.
|
